[1]
|
Eapen, R.S., Nzenza, T.C., Murphy, D.G., Hofman, M.S., Cooperberg, M. and Lawrentschuk, N. (2019) PSMA PET Applications in the Prostate Cancer Journey: From Diagnosis to Theranostics. World Journal of Urology, 37, 1255- 1261. https://doi.org/10.1007/s00345-018-2524-z
|
[2]
|
Ugai, T., Sasamoto, N., Lee, H.-Y., et al. (2022) Is Early-Onset Cancer an Emerging Global Epidemic? Current Evidence and Future Implications. Nature Reviews Clinical Oncology, 19, 656-673.
|
[3]
|
Filella, X. and Foj, L. (2018) Novel Biomarkers for Prostate Cancer Detection and Prognosis. In: Schatten, H., Ed., Cell & Molecular Biology of Prostate Cancer, Springer, Cham, 15-39. https://doi.org/10.1007/978-3-319-95693-0_2
|
[4]
|
华俊, 宋彦平, 杨媛媛, 等. 前列腺特异性膜抗原PET/CT对中高危前列腺癌初始TNM分期及临床治疗策略的影响[J]. 中国肿瘤临床, 2022, 49(16): 828-833. https://doi.org/10.12354/j.issn.1000-8179.2022.20220639
|
[5]
|
Catalona, W.J., Richie, J.P., Ahmann, F.R., et al. (2017) Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6630 Men. Journal of Urology, 197, S200-S207. https://doi.org/10.1016/j.juro.2016.10.073
|
[6]
|
Stabile, A., Giganti, F., Rosenkrantz, A.B., et al. (2020) Multipar-ametric MRI for Prostate Cancer Diagnosis: Current Status and Future Directions. Nature Reviews Urology, 17, 41-61. https://doi.org/10.1038/s41585-019-0212-4
|
[7]
|
Mohler, J.L., Armstrong, A.J., Bahnson, R.R., et al. (2016) Pros-tate Cancer, Version 1.2016. Journal of the National Comprehensive Cancer Network, 14, 19-30. https://doi.org/10.6004/jnccn.2016.0004
|
[8]
|
Parekh, D.J., Punnen, S., Sjoberg, D.D., et al. (2015) A Mul-ti-Institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-Grade Pros-tate Cancer. European Urology, 68, 464-470.
https://doi.org/10.1016/j.eururo.2014.10.021
|
[9]
|
Tosoian, J.J., Druskin, S.C., Andreas, D., et al. (2017) Use of the Prostate Health Index for Detection of Prostate Cancer: Results from a Large Academic Practice. Prostate Cancer and Prostatic Diseases, 20, 228-233.
https://doi.org/10.1038/pcan.2016.72
|
[10]
|
Dalela, D., Löppenberg, B., Sood, A., Sammon, J. and Abdollah, F. (2016) Contemporary Role of the Decipher ® Test in Prostate Cancer Management: Current Practice and Future Perspec-tives. Reviews in Urology, 18, 1-9.
|
[11]
|
Xu, M.J., Kornberg, Z., Gadzinski, A.J., et al. (2019) Genomic Risk Predicts Molecular Imaging-Detected Metastatic Nodal Disease in Prostate Cancer. European Urology Oncology, 2, 685-690. https://doi.org/10.1016/j.euo.2018.11.002
|
[12]
|
Futterer, J.J., Briganti, A., De Visschere, P., et al. (2015) Can Clin-ically Significant Prostate Cancer be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. European Urology, 68, 1045- 1053. https://doi.org/10.1016/j.eururo.2015.01.013
|
[13]
|
Kasivisvanathan, V., Rannikko, A.S., Borghi, M., et al. (2018) MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. The New England Journal of Medicine, 378, 1767-1777. https://doi.org/10.1056/NEJMoa1801993
|
[14]
|
Schoots, I.G., Roobol, M.J., Nieboer, D., Bangma, C.H., Steyerberg, E.W. and Hunink, M.G. (2015) Magnetic Resonance Imaging-Targeted Biopsy May Enhance the Di-agnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-Guided Biopsy: A Systematic Review and Meta-Analysis. European Urology, 68, 438-450. https://doi.org/10.1016/j.eururo.2014.11.037
|
[15]
|
Wibulpolprasert, P., Raman, S.S., Hsu, W., et al. (2020) Influ-ence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2. AJR. American Journal of Roentgenology, 214, 1101-1111. https://doi.org/10.2214/AJR.19.21608
|
[16]
|
Ahdoot, M., Wilbur, A.R., Reese, S.E., et al. (2020) MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. New England Journal of Medicine, 382, 917-928. https://doi.org/10.1056/NEJMoa1910038
|
[17]
|
Weinreb, J.C., Barentsz, J.O., Choyke, P.L., et al. (2016) PI-RADS Prostate Imaging-Reporting and Data System: 2015, Version 2. European Urology, 69, 16-40. https://doi.org/10.1016/j.eururo.2015.08.052
|
[18]
|
Westphalen, A.C., McCulloch, C.E., Anaokar, J.M., et al. (2020) Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel. Radiology, 296, 76-84. https://doi.org/10.1148/radiol.2020190646
|
[19]
|
Turkbey, B., Rosenkrantz, A.B., Haider, M.A., et al. (2019) Pros-tate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Ver-sion 2. European Urology, 76, 340-351.
https://doi.org/10.1016/j.eururo.2019.02.033
|
[20]
|
Gupta, R.T., Mehta, K.A., Turkbey, B. and Verma, S. (2020) PI-RADS: Past, Present, and Future. Journal of Magnetic Resonance Imaging, 52, 33-53. https://doi.org/10.1002/jmri.26896
|
[21]
|
McClure, T.D., Margolis, D.J.A., Reiter, R.E., et al. (2012) Use of MR Imaging to Determine Preservation of the Neurovascular Bundles at Robotic-Assisted Laparoscopic Prostatectomy. Radi-ology, 262, 874-883.
https://doi.org/10.1148/radiol.11103504
|
[22]
|
Schiavina, R., Bianchi, L., Borghesi, M., et al. (2018) MRI Displays the Prostatic Cancer Anatomy and Improves the Bundles Management before Robot-Assisted Radical Prostatectomy. Journal of Endourology, 32, 315-321.
https://doi.org/10.1089/end.2017.0701
|
[23]
|
Hegde, J.V., Demanes, D.J., Veruttipong, D., et al. (2017) Pretreat-ment 3T Multiparametric MRI Staging Predicts for Biochemical Failure in High-Risk Prostate Cancer Treated with Com-bination High-Dose-Rate Brachytherapy and External Beam Radiotherapy. Brachytherapy, 16, 1106-1112. https://doi.org/10.1016/j.brachy.2017.07.008
|
[24]
|
Tan N, Shen L, Khoshnoodi P, et al. (2018) Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology. Journal of Urology, 199, 1218-1223. https://doi.org/10.1016/j.juro.2017.10.042
|
[25]
|
Van Der Leest, M., Israel, B., Cornel, E.B., et al. (2019) High Di-agnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-Naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility. European Urology, 76, 574-581. https://doi.org/10.1016/j.eururo.2019.05.029
|
[26]
|
Obmann, V.C., Pahwa, S., Tabayayong, W., et al. (2018) Diag-nostic Accuracy of a Rapid Biparametric MRI Protocol for Detection of Histologically Proven Prostate Cancer. Urology, 122, 133-138.
https://doi.org/10.1016/j.urology.2018.08.032
|
[27]
|
Fraum, T.J., Ludwig, D.R., Kim, E.H., Schroeder, P., Hope, T.A. and Ippolito, J.E. (2018) Prostate Cancer PET Tracers: Essentials for the Urologist. The Canadian Journal of Urology, 25, 9371-9383.
|
[28]
|
Werner, R.A., Derlin, T., Lapa, C., et al. (2020) 18F-Labeled, PSMA-Targeted Radio-tracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging. Theranostics, 10, 1-16.
https://doi.org/10.7150/thno.37894
|
[29]
|
Eiber, M., Weirich, G., Holzapfel, K., et al. (2016) Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. European Urology, 70, 829-836. https://doi.org/10.1016/j.eururo.2015.12.053
|
[30]
|
Hicks, R.M., Simko, J.P., Westphalen, A.C., et al. (2018) Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology, 289, 730-737.
https://doi.org/10.1148/radiol.2018180788
|
[31]
|
Park, S.Y., Zacharias, C., Harrison, C., et al. (2018) Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate-or High-Risk Prostate Cancer. Radiology, 288, 495-505. https://doi.org/10.1148/radiol.2018172232
|
[32]
|
Satapathy, S., Singh, H., Kumar, R. and Mittal, B.R. (2021) Diag-nostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients with Suspected Prostate Cancer: A Systematic Review and Meta-Analysis. AJR. American Journal of Roentgenologyl, 216, 599-607.
|
[33]
|
Cysouw, M.C.F., Jansen, B.H.E, Van De Brug, T., et al. (2021) Machine Learning-Based Analysis of [18F]DCFPyL PET Radiomics for Risk Stratification in Primary Prostate Cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48, 340-349.
|
[34]
|
Maurer, T., Gschwend, J.E., Rauscher, I., et al. (2016) Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. Journal of Urology, 195, 1436-1443. https://doi.org/10.1016/j.juro.2015.12.025
|
[35]
|
Van Leeuwen, P.J., Emmett, L., Ho, B., et al. (2017) Prospective Evaluation of 68Gallium-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Preoperative Lymph Node Staging in Prostate Cancer. BJU International, 119, 209-215. https://doi.org/10.1111/bju.13540
|
[36]
|
Kim, S.J., Lee, S.W. and Ha, H.K. (2019) Diagnostic Performance of Radi-olabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Meta-Analysis. Urologia Internationalis, 102, 27-36. https://doi.org/10.1159/000493169
|
[37]
|
Nandurkar, R., Van Leeuwen, P., Stricker, P., et al. (2019) 68Ga-HBEDD PSMA-11 PET/CT Staging Prior to Radical Prostatectomy in Prostate Cancer Patients: Diagnostic and Predictive Value for the Biochemical Response to Surgery. British Journal of Radiology, 92, Article 20180667. https://doi.org/10.1259/bjr.20180667
|
[38]
|
Brauchli, D., Singh, D., Chabert, C., Somasundaram, A. and Collie, L. (2020) Tumour-Capsule Interface Measured on 18F-DCFPyL PSMA Positron Emis-sion Tomography/CT Imaging Comparable to Multi-Parametric MRI in Predicting Extra-Prostatic Extension of Prostate Cancer at Initial Staging. Journal of Medical Imaging and Radiation Oncology, 64, 829-838. https://doi.org/10.1111/1754-9485.13084
|
[39]
|
Donswijk, M.L., Van Leeuwen, P.J., Vegt, E., et al. (2020) Clinical Impact of PSMA PET/CT in Primary Prostate Cancer Compared to Conventional Nodal and Distant Staging: A Retro-spective Single Center Study. BMC Cancer, 20, Article No. 723. https://doi.org/10.1186/s12885-020-07192-7
|